ResearcherHiroshima UniversityNo recent work listed
Toshio Noriyuki
Matched on ORCID iD 0000-0002-0037-0496; OpenAlex author ID A5056125394. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 3
- Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer. Last author DOI 10.1016/j.ejso.2020.09.008↗
- Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.ejso.2018.04.022↗
- Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. Last author DOI 10.21873/anticanres.12031↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keiji Hanada · 3 shared papers, 2017–2021 · strength 0.30
- Paper Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative s… DOI 10.1016/j.ejso.2020.09.008↗
- Paper Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2018.04.022↗
- Paper Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. DOI 10.21873/anticanres.12031↗
- Tomoyuki Abe · 3 shared papers, 2017–2021 · strength 0.30
- Paper Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative s… DOI 10.1016/j.ejso.2020.09.008↗
- Paper Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. DOI 10.1016/j.ejso.2018.04.022↗
- Paper Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma. DOI 10.21873/anticanres.12031↗
- Shuji Yonehara · 1 shared paper, 2017 · strength 0.06
- Tomoyuki Minami · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.